4 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow brilacidin: new trials by email Literature Review of brilacidin trials Research Report on brilacidin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19 Brilacidin, Placebo, Standard of Care (SoC) - COVID-19 | Phase 2 | Completed | Innovation Pharmaceuticals, Inc. | 120 | 2021-02-22 | 2022-09-16 |
| A Study to Investigate the Use of Delayed Release Tablets for Colonic Delivery of Brilacidin in Healthy Volunteers Brilacidin, Placebo, 4Mq 99mTc-DTPA - Healthy Volunteers | Phase 1 | Completed | Innovation Pharmaceuticals, Inc. | 9 | 2020-01-06 | 2020-02-24 |
| Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer Brilacidin, Placebo - Head and Neck Neoplasms, Mucositis | Phase 2 | Completed | Innovation Pharmaceuticals, Inc. | 61 | 2014-08-14 | 2019-01-16 |
| Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections Daptomycin, Brilacidin - Skin Infection, Bacterial Infection | Phase 2 | Completed | Cellceutix Corporation | 215 | 2014-02-01 | 2018-09-26 |
Abscess (1) · Bacterial Infections (1) · COVID-19 (1) · Cellulitis (1) · Coronavirus Infections (1) · Erysipelas (1) · Head and Neck Neoplasms (1) · Mucositis (1) · Staphylococcal Infections (1) · Stomatitis (1) · Wound Infection (1)
Innovation Pharmaceuticals, Inc. (3) · Cellceutix Corporation (1)
United States (3) · Russia (1) · United Kingdom (1)
Howard Stevens, PhD (1) · William O'Riordan, MD (1)
2019 (1)